EDGE accelerates early discovery by integrating single-cell microscopy with AI-driven analytics, providing direct, detailed visualizations and quantification of cellular mechanisms. Early understanding of the environment and features to be targeted significantly enhances pharmaceutics and biological solution development, by early identifying and quantifying crucial biological interactions and effects.
EDGE enhances candidate selection by quantifying multiple descriptors that underlie each candidate’s behavior. For example, for delivery of pharmaceutics, this means quantification of delivery, cell entry pathways, and cellular fate in real time through advanced single-cell microscopy and AI analytics. This precision enables the informed identification of optimal candidates for further development.
EDGE strengthens IP and regulatory frameworks by precisely provide quantitative, critical, defensible evidence of unique biological mechanisms essential for regulatory approval and intellectual property protection. For drug delivery this means quantification of the diverse cell entry pathways, cellular fate and delivery efficiency using single-cell imaging and AI analytics.
EDGE enhances marketing and educational strategies by seamlessly combining alluring visualization alongside quantitative analysis. Our unique approach effectively demonstrates efficacy and mechanisms, supporting superior market positioning and educational outreach.
